EDIT - Editas Medicine - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

EDIT is currently covered by 17 analysts with an average price target of $9.94. This is a potential upside of $2.5 (33.6%) from yesterday's end of day stock price of $7.44.

Editas Medicine's activity chart (see below) currently has 51 price targets and 83 ratings on display. The stock rating distribution of EDIT is 11.11% SELL, 46.67% BUY and 42.22% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.49% with an average time for these price targets to be met of 127.72 days.

Highest price target for EDIT is $20, Lowest price target is $8, average price target is $9.94.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 29-Feb-2024. First documented stock forecast 29-Feb-2016.

Currently out of the existing stock ratings of EDIT, 5 are a SELL (11.11%), 21 are a BUY (46.67%), 19 are a HOLD (42.22%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

11

$3.56 (47.85%)

17

28 days ago

5/6 (83.33%)

$0.94 (9.34%)

235

Buy

20

$12.56 (168.82%)

35

3 months 16 days ago

1/5 (20%)

$10.16 (103.25%)

3

Buy

9

$1.56 (20.97%)

15

5 months 28 days ago

3/5 (60%)

$1.2 (15.38%)

28

Buy

14

$6.56 (88.17%)

14

6 months 15 days ago

0/6 (0%)

$5.53 (65.29%)

Buy

19

$11.56 (155.38%)

22

7 months 25 days ago

1/9 (11.11%)

$9.69 (104.08%)

617

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is EDIT (Editas Medicine) average time for price targets to be met?

On average it took 127.72 days on average for the stock forecasts to be realized with a an average price target met ratio 48.49

Which analyst has the current highest performing score on EDIT (Editas Medicine) with a proven track record?

STEVEN SEEDHOUSE

Which analyst has the most public recommendations on EDIT (Editas Medicine)?

Steven Seedhouse works at RAYMOND JAMES and has 18 price targets and 16 ratings on EDIT

Which analyst is the currently most bullish on EDIT (Editas Medicine)?

Yanan Zhu with highest potential upside - $22.56

Which analyst is the currently most reserved on EDIT (Editas Medicine)?

Matthew Harrison with lowest potential downside - -$0.44

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?